The global digital diabetes management market, valued at USD 11.8 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The rapid growth in this sector is primarily driven by the increasing global prevalence of diabetes and the continuous advancements in digital technology. According to the International Diabetes Federation, 537 million adults...

The global digital diabetes management market reached a value of USD 11.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. This strong growth is largely driven by the rising global prevalence of diabetes, as well as continuous advancements in digital technology and innovative solutions for disease management. According to the...

The global digital diabetes management market was valued at USD 11.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The significant growth of this market is largely driven by the rising prevalence of diabetes and advancements in digital technology. According to the International Diabetes Federation, approximately 537 million adults...

U.S. Diabetic Retinopathy Market Summary The U.S. diabetic retinopathy market size was estimated at USD 3.02 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2030. This anticipated growth is driven by multiple key factors, including the expanding geriatric population, a surge in diabetes cases due to sedentary lifestyles and poor...

The Smart Insulin Pens Market size was valued at USD 877.26 million in 2024 and is forecasted to more than double, reaching USD 1,818.89 million by 2032. This expansion reflects a compound annual growth rate (CAGR) of 9.57% during the forecast period of 2025 to 2032. The market’s rise is being fueled by a combination of advancing medical technologies, an increasing diabetes...